Indian Potash Limited- FY26 Results

13 August 2026

Cost of goods sold (materials consumed + trading purchases, net of inventory movement) rose from ~83.3% to ~85.0% of revenue - the trading business scaled with a slightly thinner gross spread, largely because the mix shifted further toward lower-margin purchases of stock-in-trade (fertiliser trading) versus in-house materials consumption. Finance costs jumped from ~2.4% to ~3.6% of revenue, reflecting the much larger working-capital borrowings needed to fund the bigger trading book. Employee costs and other expenses improved slightly as a share of revenue, showing some operating cost leverage even as gross margin narrowed.

Indian Potash Limited (IPL) operates as one of India's largest fertiliser importers and distributors, with its core business centered on sourcing and marketing Muriate of Potash, Di-Ammonium Phosphate, Sulphate of Potash, and Urea across the country - including remote and inaccessible regions - through an extensive network of Regional offices covering nearly every State capital. Its distribution model leans heavily on India's agricultural cooperative structure and direct farmer engagement, backed by nationwide farmer education initiatives, product literacy campaigns, and sales outreach programs run in multiple regional languages. Beyond its fertiliser trading and distribution mandate, IPL has diversified into allied agri and consumer businesses, including manufacturing of Cattle feed products, Milk and milk products, Sulphitation and refined Sugar, Distillery operations, and trading in Gold and other precious metals - giving the company a multi-segment revenue base anchored around, but not limited to, its position in India's fertiliser supply chain. The Company, incorporated and headquartered in Chennai, Tamil Nadu, also plays a quasi-strategic role in the sector given its past mandate for global tender-based procurement of key fertilisers on behalf of the industry, reflecting close alignment with government food-security and farmer-welfare objectives.

1. Revenue, EBITDA, Net Profit & EPS Summary (Rs in Cr)

Revenue surged ~57.6% YoY, driven largely by the trading (purchases of stock-in-trade) line rather than in-house manufacturing. Operating EBITDA grew more slowly at ~50.5%, and margin actually compressed slightly, as finance costs rose sharply alongside a much larger trading book. Consolidated net profit grew a more modest ~19.3%, diluting the consolidated margin even as absolute profit rose. EPS growth mirrors NP growth since the share count was unchanged.

2. Common-Size Statement 

Cost of goods sold (materials consumed + trading purchases, net of inventory movement) rose from ~83.3% to ~85.0% of revenue - the trading business scaled with a slightly thinner gross spread, largely because the mix shifted further toward lower-margin purchases of stock-in-trade (fertiliser trading) versus in-house materials consumption. Finance costs jumped from ~2.4% to ~3.6% of revenue, reflecting the much larger working-capital borrowings needed to fund the bigger trading book. Employee costs and other expenses improved slightly as a share of revenue, showing some operating cost leverage even as gross margin narrowed.

3. Key Balance Sheet Items (Rs in Cr)

4. Key Ratio Analysis